Bill & Melinda Gates Medical Research Institute

We are a research organization dedicated to better understanding the roots of disease and narrowing the gap between new biological insights and impact for patients. We are committed to characterizing psychiatric disorders' molecular roots and turning new findings into new treatments. We are fostering a diverse research community engaged in innovative chemical biology and therapeutic research. The mission of the Broad Institute of MIT and Harvard is to better understand the roots of disease and narrow the gap between new biological insights and impact for patients. The Broad Institute of MIT and Harvard is a research organization that convenes a community of researchers from across many disciplines and partner institutions—MIT, Harvard, and Harvard-affiliated hospitals. Based in Cambridge, Massachusetts, the Broad Institute was founded in 2004 to fulfill the promise of genomic medicine—three years after completion of the Human Genome Project, which Broad scientists helped create and lead. Our researchers are deeply collaborative, nimbly launching innovative, high-risk projects at every scale, gaining insight into the biological mechanisms of disease, inventing new technologies, building and implementing computational tools, developing new therapeutics to advance into the clinic, mentoring and training the next generation of scientists, and sharing our data and tools openly to enable breakthroughs anywhere. We work with researchers and patients to tackle important challenges in biomedicine and find innovative, high-impact solutions.

BVGH is a results-oriented nonprofit organization dedicated to solving global health issues by forming connections between people, resources, and ideas. BVGH envisions a world in which everyone has the opportunity to live a productive and healthy life. BVGH strategically develops and manages programs across the for-profit and non-profit sectors to catalyze innovative research and development (R&D); expand research and healthcare capacity in low- and middle-income countries (LMICs); and increase access to high-quality health care. BVGH is thrilled to be part of the Clinical Trials Community Africa Network project, a bold step towards a coordinated and sustainable clinical trials network in Africa. BIO Ventures for Global Health (BVGH) is a nonprofit organization based in Seattle, Washington working at the crossroads of the private and public sectors to sustainably foster innovation ecosystems and health equity in low- and middle-income countries (LMICs). Driven by LMICs’ self-defined needs, and working across geographies and therapeutic areas, BVGH establishes public-private partnerships that catalyze innovative research, from discovery through clinical trials; expand LMICs’ research and healthcare capacity; and increase access to high-quality health care. We have been, and must continue to be, leaders, experts, innovators, and—most importantly—partners in global efforts to reduce suffering and the burden of disease”.

Our mission is to improve the health of millions of people worldwide, particularly those living in disadvantaged circumstances, by challenging the status quo and using innovative approaches to prevent and treat non-communicable diseases and injury. The George Institute was established in Sydney, Australia in 1999 to tackle the escalating burden of non-communicable diseases and injury around the world, with a focus on underserved populations. We are a leading independent global medical research institute focused on the world’s biggest health challenges. We are raising funds to support research posts, fellowships programs and infrastructure across our major centres in Australia, India, China and the UK. The George Institute is a leading independent global medical research institute with major centres in Australia, China, India and the UK, and an international network of experts and collaborators. Through a program of research, advocacy/thought leadership, and disruptive social entrepreneurship, we are driving global impact. We work with some of the world’s best leaders and experts in their field. Our Board of Directors supports and guides us in our mission to improve the health of millions of people globally.

Improving plant biology offers the potential for transformations that are renewable, affordable, and scalable. Gates Ag One is a subsidiary of the Bill & Melinda Gates Foundation, set up specifically to harness this natural solution for development impact. Join a team that’s forging a new model for product development — one focused on translating the world’s most potentially impactful science into public goods that are accessible where they’re needed most.

We can't achieve our goals on our own. For 20 years, the Bill & Melinda Gates Foundation has been committed to fighting the greatest inequities in the world. To ensure transparency and access, the foundation provides information on various policies, statements, and definitions. Our database includes payments made and committed from 1994 onward.

Our aim is that through our grantmaking, partnerships and investments, we will accelerate ideas and early-stage biomedical discovery that will save and enhance lives. We have three primary functions that ensure biomedical innovation, education and economic development. We look for opportunities to deepen our existing relationships and collaborate with organizations and partners to invest in transformational ideas to advance our strategic goals. We have invested over $205 million in biomedical research, discovery, and health initiatives in Oklahoma, all with the goal of enhancing and saving lives. Scientific breakthroughs that enable life-saving cures and treatments can only be possible through research.